Eli Lilly | LLY - Capitalización De Mercado





Capitalización De Mercado Cambio Fecha
AbbVie USD 446.03B 61.34B 2026-07
Abbott USD 175.87B 17.82B 2026-07
ALKERMES USD 8.17B 562M 2026-07
Amgen USD 189.89B 13.64B 2026-03
AstraZeneca USD 197.73B 92.26B 2026-07
Baxter International USD 13.65B 2.64B 2026-07
Biogen USD 30.52B 1.38B 2026-07
Bristol-Myers Squibb USD 131.55B 13.89B 2026-07
Coherus Biosciences USD 172M 19M 2025-12
Drreddys Laboratories INR 2.41B 8.66B 2026-07
Eli Lilly USD 869.02B 146.97B 2026-03
Gilead Sciences USD 172.99B 20.71B 2026-03
GlaxoSmithKline GBP 81.74B 1.6B 2026-07
Glaxosmithkline GBP 108.55B 736M 2026-07
J&J USD 602.98B 8.38B 2026-07
Merck USD 297.1B 35.84B 2026-03
Neurocrine Biosciences USD 18.46B 1.51B 2026-07
Novartis USD 264.25B 23.66B 2026-07
Novartis USD 319.89B 31.63B 2026-07
Novo Nordisk A/S DKK 1.03T 421.31B 2026-03
Perrigo USD 1.31B 604M 2026-03
Pfizer USD 153.81B 12.24B 2026-03
Phibro Animal Health USD 1.51B 126M 2025-12
Prestige Brands USD 2.8B 161M 2026-03
Regeneron Pharmaceuticals USD 81.04B 15.67B 2026-07
Roche Holding CHF 235.82B 34.18B 2026-07
Sanofi EUR 93.07B 1.91B 2026-07
Sanofi EUR 108.52B 5B 2026-07
United Therapeutics USD 25.19B 4.21B 2026-03
Zoetis USD 49.71B 5.74B 2026-03